Concepedia
Statistics
Publications
1
Citations
10
H-Index
Active since
2014
M. Merqui-Roelvink is an author specializing in pharmacology, pharmacodynamics of anticancer agents, and clinical pharmacology.
Publications per year
2014–2014
378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies
Vincent de Weger, Martijn P. Lolkema, Mark A. Dickson et al. · European Journal of Cancer · 2014 · 10 citations
Medicine, Oncology, Pharmacology +6
1–1 of 1